Sun, Beicheng
First Affiliated Hospital of Anhui Medical University
7 papers on CoChatORCID 0000-0002-8657-7024
Most cited papers
- Verified
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 545
- Verified
NF-κB signaling, liver disease and hepatoprotective agents
Sun, B., & Karin, M. (2008) · Oncogene
NF-κB Signaling PathwaysLiver physiology and pathology
Cited by 307
- Verified
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity
Phagocytosis and Immune RegulationLiver Disease Diagnosis and Treatment
Cited by 262
- Verified
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome
Su, H., Yang, F., Fu, R., Trinh, B., Sun, N., Liu, J., Kumar, A., Baglieri, J., Siruno, J., Le, M., et al. (2022) · Nature
Pancreatic and Hepatic Oncology ResearchProtease and Inhibitor Mechanisms
Cited by 221
- Verified
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
Dai, H., Zhu, C., Huai, Q., Xu, W., Zhu, J., Zhang, X., Zhang, X., Sun, B., Xu, H., Zheng, M., et al. (2024) · Journal of Hepatology
Liver physiology and pathologyLiver Disease Diagnosis and Treatment
Cited by 114
- Verified
IL-22 Signaling in the Tumor Microenvironment
Jiang, R., & Sun, B. (2021) · Advances in Experimental Medicine and Biology
Cytokine Signaling Pathways and InteractionsCancer Immunotherapy and Biomarkers
Cited by 35
- Verified
Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis
Wu, P., Luo, X., Sun, M., Sun, B., & Sun, M. (2022) · Biomaterials
Liver physiology and pathologyRNA Interference and Gene Delivery
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free